Literature DB >> 12882831

T-bet regulates T-independent IgG2a class switching.

Andrea J Gerth1, Ling Lin, Stanford L Peng.   

Abstract

The IgG2a Ig subclass plays a critical role in the pathogenesis of humoral autoimmunity and protection against pathogens. The T-box transcription factor T-bet has been implicated as a critical mediator of class-switch recombination (CSR) to IgG2a, but its relative importance to this process in various immune contexts remains incompletely defined. We report here that, surprisingly, T-bet is selectively required for IgG2a class switching in response to T-independent, but not T-dependent, stimuli. Specifically, T-dependent signaling through CD40, in contrast to T-independent signaling via lipopolysaccharide, can bypass a requirement for T-bet in IgG2a germline transcription and subsequent isotype switching. In contrast, T-bet-deficient B cells undergo class switching to other IgG isotypes at least as well as wild-type counterparts. Thus, T-bet is a class-specific regulator of IgG CSR and represents a unique regulator of B cell differentiation by participating in a T-independent, but not a T-dependent, activation pathway. T-bet-deficient B cells therefore represent a novel paradigm by which to investigate the regulation of humoral immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12882831     DOI: 10.1093/intimm/dxg093

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  54 in total

Review 1.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

2.  Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells.

Authors:  Martin S Naradikian; Arpita Myles; Daniel P Beiting; Kenneth J Roberts; Lucas Dawson; Ramin Sedaghat Herati; Bertram Bengsch; Susanne L Linderman; Erietta Stelekati; Rosanne Spolski; E John Wherry; Christopher Hunter; Scott E Hensley; Warren J Leonard; Michael P Cancro
Journal:  J Immunol       Date:  2016-07-18       Impact factor: 5.422

3.  Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response.

Authors:  C-M Fang; S Roy; E Nielsen; M Paul; R Maul; A Paun; F Koentgen; F M Raval; E Szomolanyi-Tsuda; P M Pitha
Journal:  Genes Immun       Date:  2012-04-26       Impact factor: 2.676

Review 4.  Toll-like receptors--sentries in the B-cell response.

Authors:  Isabelle Bekeredjian-Ding; Gaetan Jego
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

Review 5.  T-bet in disease.

Authors:  Vanja Lazarevic; Laurie H Glimcher
Journal:  Nat Immunol       Date:  2011-06-20       Impact factor: 25.606

Review 6.  T-bet-expressing B cells during HIV and HCV infections.

Authors:  James J Knox; David E Kaplan; Michael R Betts
Journal:  Cell Immunol       Date:  2017-07-11       Impact factor: 4.868

Review 7.  Atypical memory B cells in human chronic infectious diseases: An interim report.

Authors:  Silvia Portugal; Nyamekye Obeng-Adjei; Susan Moir; Peter D Crompton; Susan K Pierce
Journal:  Cell Immunol       Date:  2017-07-11       Impact factor: 4.868

8.  T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response.

Authors:  James J Knox; Marcus Buggert; Lela Kardava; Kelly E Seaton; Michael A Eller; David H Canaday; Merlin L Robb; Mario A Ostrowski; Steven G Deeks; Mark K Slifka; Georgia D Tomaras; Susan Moir; M Anthony Moody; Michael R Betts
Journal:  JCI Insight       Date:  2017-04-20

9.  Generation of functional murine CD11c+ age-associated B cells in the absence of B cell T-bet expression.

Authors:  Samuel W Du; Tanvi Arkatkar; Holly M Jacobs; David J Rawlings; Shaun W Jackson
Journal:  Eur J Immunol       Date:  2018-11-05       Impact factor: 5.532

10.  IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice.

Authors:  Donna L Thibault; Alvina D Chu; Kareem L Graham; Imelda Balboni; Lowen Y Lee; Cassidy Kohlmoos; Angela Landrigan; John P Higgins; Robert Tibshirani; Paul J Utz
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.